Nevertheless, it is intriguing that molecular determinants (TGF-β, mTOR and STAT3) either in the glioblastoma cellular states and/or in the tumour microenvironment converge as regulators of NBCe1 activity. The gene discussed is STAT3; the disease is glioblastoma.